Literature DB >> 12928081

Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence.

Edward M Weaver1.   

Abstract

This study was conducted to review and evaluate the published evidence for an association between gastroesophageal reflux (GER) and 3 supraesophageal pathologies: sinusitis, otitis media, and laryngeal malignancy. Relevant articles were located using MEDLINE (search limits: 1966-2001, English language, human studies). Only new data or new analyses of previous data were included. Relevant articles were designated by their level of evidence, based on published standards, and grouped by pathology. An overall grade was assigned to each group for the strength of evidence for or against an association. The search produced 152 articles, 42 of which met inclusion criteria and were reviewed in detail. There is grade C evidence for a positive association between GER and sinusitis (57 articles screened, 14 articles included); for a negative association between GER and otitis media (28 articles screened, 10 articles included); and for a positive association between GER and laryngeal malignancy (67 articles screened, 18 articles included). The published literature weakly supports a positive association between GER and both sinusitis and laryngeal malignancy, and a negative association between GER and otitis media.

Entities:  

Mesh:

Year:  2003        PMID: 12928081     DOI: 10.1016/s0002-9343(03)00203-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  Nasal manifestations of systemic illnesses.

Authors:  Isam Alobid; Jose Maria Guilemany; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

Review 2.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

Review 3.  ENT manifestations of gastro-oesophageal reflux in children.

Authors:  G Caruso; F M Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

Review 4.  Extra-laryngeal manifestations of gastro-oesophageal reflux.

Authors:  M De Benedetto; G Monaco; F Marra
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-10       Impact factor: 2.124

5.  Comparative outcomes of antireflux treatment for laryngopharyngeal reflux symptoms and upper abdominal symptoms in patients with endoscopic esophagitis.

Authors:  Ahmet Burak Toros; Sema Zer Toros; Leyla Ozel; Feyzullah Ersoz; Mustafa Saglam; Fettah Sametoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-19       Impact factor: 2.503

6.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

7.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

Review 8.  The frontiers of reflux disease.

Authors:  Nimish Vakil
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

9.  Is pepsin detected in the saliva of patients who experience pharyngeal reflux?

Authors:  A Printza; M Speletas; S Triaridis; J Wilson
Journal:  Hippokratia       Date:  2007-07       Impact factor: 0.471

Review 10.  Laryngopharyngeal reflux and chronic sinusitis.

Authors:  David Weldon
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.